Nanobiotix S.A.: Form 20-F/A for the period ended Dec 31, 2020
Filed with the SEC on Apr 8, 2021 and accepted by EDGAR at Apr 7, 2021, 18:03 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-01-01 to 2020-12-31 | EUR 2.5m | ifrs-full:Revenue |
| Operating income | 12 months2020-01-01 to 2020-12-31 | −EUR 36.4m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2020-01-01 to 2020-12-31 | EUR 9.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2020-01-01 to 2020-12-31 | −EUR 33.6m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | −EUR 1.38 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | −EUR 1.38 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | −EUR 27.5m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | EUR 96.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2020-12-31 | EUR 119.2m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2020-12-31 | EUR 125.2m | ifrs-full:CurrentAssets |
| Total assets | At period end2020-12-31 | EUR 134.0m | ifrs-full:Assets |
| Current liabilities | At period end2020-12-31 | EUR 19.0m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | At period end2020-12-31 | EUR 70.5m | ifrs-full:Equity |
| Shares outstanding | At period end2020-12-31 | 34,432,122 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001628280-21-006685. Last ingested by Listed: Oct 26, 2026, 06:02 ET. Listed shows no prices and gives no investment advice.